Dextromethorphan and guaifenesin use must be monitored very carefully in people with "lousy metabolizer" CYP2D6 enzyme amounts and patients that are sedated. This combination medication contains a big median harmful dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these people. Keep at space temperature clear of https://optimusbookmarks.com/story18155582/the-ultimate-guide-to-dextromethorphan-dxm-for-sale-in-europe